[1] |
WINNEPENNINCKX V, DE VOS R, STAS M, et al. New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma[J]. Appl Immunohistochem Mol Morphol, 2003, 11(4): 319-325.
|
[2] |
WALIA R, JAIN D, MATHUR S R, et al. Spindle cell melanoma: a comparison of the cytomorphological features with the epithelioid variant[J]. Acta Cytol, 2013, 57(6): 557-561.
doi: 10.1159/000354405
|
[3] |
KIM J, LAZAR A J, DAVIES M A, et al. BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma[J]. J Cutan Pathol, 2012, 39(9): 821-825.
doi: 10.1111/j.1600-0560.2012.01950.x
|
[4] |
PIAO Y C, GUO M, GONG Y. Diagnostic challenges of metastatic spindle cell melanoma on fine-needle aspiration specimens[J]. Cancer, 2008, 114(2): 94-101.
doi: 10.1002/cncr.23345
|
[5] |
BANERJEE S S, HARRIS M. Morphological and immunophenotypic variations in malignant melanoma[J]. Histopathology, 2000, 36(5): 387-402.
doi: 10.1046/j.1365-2559.2000.00894.x
|
[6] |
MORGAN M B, PUROHIT C, ANGLIN T R. Immunohistochemical distinction of cutaneous spindle cell carcinoma[J]. Am J Dermatopathol, 2008, 30(3): 228-232.
doi: 10.1097/DAD.0b013e31816de820
|
[7] |
STOWMAN A M, MILLS S E, WICK M R. Spindle cell melanoma and interdigitating dendritic cell sarcoma: do they represent the same process?[J]. Am J Surg Pathol, 2016, 40(9): 1270-1279.
doi: 10.1097/PAS.0000000000000678
|
[8] |
TACHA D, QI W M, RA S, et al. A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas[J]. Arch Pathol Lab Med, 2015, 139(4): 530-536.
doi: 10.5858/arpa.2014-0077-OA
|
[9] |
RAWANDALE N A, SURYAWANSHI K H. Primary spindle cell malignant melanoma of esophagus: an unusual finding[J]. J Clin Diagn Res, 2016, 10(2): OD03-OD04.
|
[10] |
DAINICHI T, KOBAYASHI C, FUJITA S, et al. Interdigital amelanotic spindle-cell melanoma mimicking an inflammatory process due to dermatophytosis[J]. J Dermatol, 2007, 34(10): 716-719.
doi: 10.1111/jde.2007.34.issue-10
|
[11] |
XU Z, SHI P, YIBULAYIN F, et al. Spindle cell melanoma: Incidence and survival, 1973-2017[J]. Oncol Lett, 2018, 16(4): 5091-5099.
|
[12] |
XU Z, YIBULAYIN F, SHI P, et al. Desmoplastic melanoma versus spindle cell melanoma: incidence and survival, 1973 to 2017[J]. Medicine (Baltimore), 2018, 97(29): e11563.
doi: 10.1097/MD.0000000000011563
|
[13] |
GERSHENWALD J E, SCOLYER R A, HESS K R, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual[J]. CA Cancer J Clin, 2017, 67(6): 472-492.
doi: 10.3322/caac.21409
|
[14] |
EL SHAROUNI M A, VAREY A H R, WITKAMP A J, et al. Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort[J]. Br J Dermatol, 2021, 185(2): 412-418.
doi: 10.1111/bjd.v185.2
|
[15] |
MARCHETTI M A, LIOPYRIS K, NAVARRETE-DECHENT C. Net benefit and decision curve analysis of competing diagnostic strategies for cutaneous melanoma[J]. J Am Acad Dermatol, 2021, 85(2): e87-e88.
doi: 10.1016/j.jaad.2020.04.170
|
[16] |
IASONOS A, SCHRAG D, RAJ G V, et al. How to build and interpret a nomogram for cancer prognosis[J]. J Clin Oncol, 2008, 26(8): 1364-1370.
doi: 10.1200/JCO.2007.12.9791
|
[17] |
WACHTEL J G, CAPLAN C W, MAKLEY T A Jr. Juvenile melanoma (mixed spindle cell and epithelioid cell nevus) of the conjunctiva[J]. Surv Ophthalmol, 1967, 12(1): 12-16.
|
[18] |
HOLLMIG S T, SACHDEV R, COCKERELL C J, et al. Spindle cell neoplasms encountered in dermatologic surgery: a review[J]. Dermatol Surg, 2012, 38(6): 825-850.
doi: 10.1111/j.1524-4725.2012.02296.x
|
[19] |
BALACHANDRAN V P, GONEN M, SMITH J J, et al. Nomograms in oncology: more than meets the eye[J]. Lancet Oncol, 2015, 16(4): e173-e180.
doi: 10.1016/S1470-2045(14)71116-7
|
[20] |
GONG H Z, ZHENG H Y, LI J. Amelanotic melanoma[J]. Melanoma Res, 2019, 29(3): 221-230.
doi: 10.1097/CMR.0000000000000571
|
[21] |
XIAO Y, PENG S S, HU Y H, et al. Development and validation of prognostic nomogram in patients with nonmetastatic malignant melanoma: a SEER population-based study[J]. Cancer Med, 2020, 9(22): 8562-8570.
doi: 10.1002/cam4.v9.22
|
[22] |
VERVER D, VAN KLAVEREN D, FRANKE V, et al. Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes[J]. Br J Surg, 2019, 106(3): 217-225.
doi: 10.1002/bjs.10995
|